Quantum BioPharma Ltd.
QNTMCIK 0001771885
Revenue (TTM)
257.1K
FY Dec 2025
Net Income (TTM)
−27.27M
+33.1% YoY
FY Dec 2025
EPS Diluted (TTM)
—
FY Dec 2025
Gross Margin
-936.2%
FY Dec 2025
Operating Margin
-6,655.0%
FY Dec 2025
Net Margin
-10,606.5%
FY Dec 2025
Free Cash Flow (TTM)
—
FY Dec 2025
Cash
1.91M
FY Dec 2025
Total Debt
—
FY Dec 2025
Shares Outstanding
12 sh
FY Dec 2025
Revenue & Net Income
Margins
Cash Flow
Revenue Growth (YoY)
No data available for this metric.